Skip to main content

Day: March 24, 2022

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter and Year End 2021 Financial Results on Tuesday, March 29, 2022

BEVERLY HILLS, Calif., March 24, 2022 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (Nasdaq:TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced it will report results for the fourth quarter and year ended December 31, 2021, after the close of the financial markets on Tuesday, March 29, 2022 and will hold a conference call at 4:30 p.m. ET that day. To participate in the call by phone, dial (877) 545-0320 and entry code 624594 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0016 and use entry code 624594. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI...

Continue reading

Sopheon Announces Results for 2021

MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) — Sopheon plc, the international provider of software and services for Enterprise Innovation Management solutions, today announced its results for the year ended December 31, 2021, together with an outlook for the current year. Financial Highlights:Revenue of $34.4m, ahead of market expectations in the face of continued COVID challenges, whilst embedding the SaaS transition (2020: $30.0m) ARR1 rose from $18.0m at the start of 2021 to $20.7m at the end of the year Full year 2022 revenue visibility2 stands at $25.1m (last year at this time: $24.5m) Gross retention at 95% (2020: 91.5%) Adjusted EBITDA3 of $6.2m (2020: $5.9m) also ahead of market expectations Profit before tax of $1.2m (2020: $1.7m) affected by higher amortization and share based payments Net cash of $24.2m (2020: $21.7m)...

Continue reading

Harbor Custom Development, Inc. Reports 2021 Fourth Quarter and Full Year Results and Provides Full Year 2022 Outlook

Continued Strength in Buyer Demand Drives Full Year Sales Increase of 43.6% GIG HARBOR, Wash., March 24, 2022 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes®,” or the “Company”), (NASDAQ: HCDI; HCDIP; HCDIW, HCDIZ), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced its financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Financial Highlights Compared to Fourth Quarter 2020Consolidated net sales of $26.3 million compared to $24.3 million Gross profit of $10.9 million compared to $0.4 million Gross margin of 41.2% compared to 1.5% Net income of $5.6 million, or $0.26 basic earnings per share (EPS), compared to a net loss of $(1.9) million, or $(0.34) loss per share EBITDA of...

Continue reading

ST. JAMES GOLD CORP. (TSXV: LORD) ANNOUNCES APPOINTMENT OF LEIGH HUGHES TO ITS BOARD OF DIRECTORS

Not for distribution to U.S. news wire services or dissemination in the United States. Vancouver, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to announce that, effective immediately, the Company has appointed Leigh Hughes to its board of Directors. Mr. Hughes is an entrepreneur and venture capitalist who has over 20 years’ experience working with private and public companies across the globe, in particular North America, Australia and the Asia Pacific Region. Mr. Hughes is the Founder of COMVERJ Ventures which helps clients identify opportunities for change in the fields of mergers & acquisitions, capital markets, business strategy and innovation. COMVERJ Ventures has worked with numerous public companies in United States, Canada,...

Continue reading

New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System

Study published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunction DEERFIELD, Ill., March 24, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the publication of results from EVoluSIon (EVSI), a large, prospective, multi-center study of clinical outcomes following minimally invasive sacroiliac joint (SIJ) fusion with decortication. Published in the February 2022 issue of the International Journal of Spine Surgery, Clinical Outcomes Following Minimally Invasive Sacroiliac Joint Fusion with Decortication: The EVoluSIon Clinical Study1, reports 12-month clinical outcomes following minimally invasive SIJ fusion using the SImmetry Sacroiliac Joint Fusion...

Continue reading

Udemy Named #5 on the List of Best Midsize Workplaces in Ireland

Dublin Office Named as One of Ireland’s Best Mid-Sized Workplaces Overall and a Best Workplace for Women SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced that Great Place to Work® has honored the company as number 5 on the list of Ireland’s Best Medium Workplaces in 2022. Additionally, Udemy’s Dublin office has been recognised as a 2022 Best Workplace for Women, which recognises top organisations with women-friendly policies and benefits, on top of creating a positive and supportive workplace. “We’re thrilled to be ranked No. 5 Best Midsize Workplace in Ireland and recognised as one of the Best Workplaces for Women,” said Bill O’Shea, Udemy Vice President of EMEA. “These accolades are a testament to our talented Udemates and our incredible...

Continue reading

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops

Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States in 2017. Those offerings expanded to include plant health solutions, particularly in the European market, with the acquisition of Pro Farm in 2019. Today, more than 30% of MBI’s annual revenues come from seed technologies used on approximately 35 million acres of major row crops such as corn,...

Continue reading

Rubicon Technologies to Host Virtual Analyst & Investor Day on April 12, 2022

Lexington, Kentucky, March 24, 2022 (GLOBE NEWSWIRE) — Rubicon Technologies, LLC (“Rubicon” or “the Company”), a digital marketplace for waste and recycling and provider of innovative software-based solutions for businesses and governments worldwide, and Founder SPAC (Nasdaq: FOUN) (“Founder”), a publicly-traded special purpose acquisition company, today announced Rubicon will be hosting a Virtual Analyst & Investor Day on Tuesday, April 12, 2022 at 11:00 am EDT. During the two-hour virtual event, members of the Rubicon and Founder SPAC executive teams will provide an overview of the Company, an established global leader in providing cloud-based waste and recycling solutions to businesses and governments around the world. In addition, the formal presentation will be followed by a live question and answer session hosted by...

Continue reading

Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting

DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology’s (AAD) 2022 Annual Meeting. Details of the abstract presentation are as follows:Title: Berdazimer 10.3% Gel (SB206): A Novel, Topical Nitric Oxide Releasing Medication: Results from a Pivotal Phase 3 Study in Patients (Children and Adults) with Molluscum ContagiosumSession:   Clinical Studies/PediatricDate & Time: March 26, 2022, at 10:20am ETLocation: Rm. 253AThe presentation will be given by Dr. John Browning M.D., F.A.A.D, F.A.A.P., MBA, Adjunct Associate Professor of Pediatrics...

Continue reading

NSAV Announces Launch of HIVE, the First Blockchain Home Mining Device that Can Mine Multiple Tokens

$NSAV Announces Launch of HIVE, the First Blockchain Home Mining Device that Can Mine Multiple Tokens HIVE, the world’s first blockchain home mining deviceLondon, England, March 24, 2022 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced, in partnership with Metaverse Network LLC. (MNC) https://metaversenetwork.llc/, the launch of HIVE, the world’s first blockchain home mining device able to mine multiple tokens https://hive.codes/. New developer listings can park with our Blockchain and can experience “1 DEVICE ALL MINE” (multiple chain mining). Developers can publish their regulatory subscription conditions in our HIVE App’s CRYPTO STORE. When subscribers synchronize selected CRYPTO to mine, they will be able to mine their selections,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.